Skip to content
10-K

Annual Report

QLY BIOTECH GROUP CORP.

0001477932-20-005756

← back to feed
Filed
Oct 6, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Oct 5, 2020 3.9M sh
Operating Income FY 2020 · Aug 31, 2020 $6.31K
Capex FY 2020 · Aug 31, 2019 $0
Operating Cash Flow FY 2020 · Aug 31, 2019 −$978
Current Liabilities FY 2020 · Aug 31, 2019 $2.98K
Total Liabilities FY 2020 · Aug 31, 2019 $2.98K
Current Assets FY 2020 · Aug 31, 2019 $5K
Total Assets FY 2020 · Aug 31, 2019 $5K
Sga Expense FY 2020 · Aug 31, 2019 $978
Net Income FY 2020 · Aug 31, 2019 −$978
Net Income FY 2020 · Aug 31, 2019 −$978
Revenue FY 2020 · Aug 31, 2019 $0
Stockholders Equity FY 2020 · Sep 20, 2018 $0
Cash And Equivalents FY 2020 · Sep 19, 2018 $0